The murine AIDS virus Gag precursor protein binds to the SH3 domain of c-Abl

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2615-2620

  Dupraz, Philippe ^a   Rebai, Najet ^a   Klein, Steven J ^a   Beaulieu, Normand ^a   Jolicoeur, Paul ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; ONCOPROTEIN; PROTEIN PRECURSOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL LINE; CONTROLLED STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RODENT DISEASE; SACCHAROMYCES CEREVISIAE; VIRUS CELL INTERACTION;

EID: 0030932978     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2615-2620.1997     Document Type: Article

References (43)

1. Alexandropoulos, K., G. Cheng, and D. Baltimore. 1993. Proline-rich sequences that bind to src homology 3 domains with individual specificities. Proc. Natl. Acad. Sci. USA 92:3110-3114.
2. Aziz, D. C., Z. Hanna, and P. Jolicoeur. 1989. Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature 338:505-508.
3. Breeden, L., and K. Nasmyth. 1985. Regulation of the yeast HO gene. Cold Spring Harbor Symp. Quant. Biol. 50:643-650.
4. Chattopadhyay, S. K., H. C. Morse 3d, M. Makino, S. K. Ruscetti, and J. W. Hartley. 1989. Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA 86: 3862-3866.
5. Chesebro, B., W. Britt, L. Evans, K. Wehrly, J. Nishio, and M. Cloyd. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148.
6. Cicchetti, P., B. J. Mayer, G. Thiel, and D. Baltimore. 1992. Identification of a protein that binds to the SH3 region of abl and is similar to ber and GAP-rho. Science 257:803-806.
7. Dai, Z., and A. M. Pendergast. 1995. Abi-2, a novel SH3-containing protein interacts with the c-abl tyrosine kinase and modulates c-abl transforming activity. Genes Dev. 9:2569-2582.
8. Daley, G. Q., R. A. Van Etten, P. K. Jackson, A. Bernards, and D. Baltimore. 1992. Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line. Mol. Cell. Biol. 12:1864-1871.
9. Daniel, R., P. M. C. Wong, and S. W. Chung. 1996. Isoform-specific functions of c-abl: type I is necessary for differentiation, and type IV is inhibitory to apoptosis. Cell Growth Differ. 7:1141-1148.
10. Doyon, L., C. Simard, R. P. Sekaly, and P. Jolicoeur. 1996. Evidence that the murine AIDS defective virus does not encode a superantigen. J. Virol. 70:1-9.
11. Feller, S. M., B. Knudsen, and H. Hanafusa. 1994. C-abl kinase regulates the protein binding activity of c-crk. EMBO J. 13:2341-2351.
12. Fields, S., and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245-246.
13. Franz, W. M., P. Berger, and J. Y. Wang. 1989. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential. EMBO J. 8:137-147.
14. gag protein for efficient induction of disease. J. Virol. 69:60-68.
15. Huang, M., and P. Jolicoenr. 1990. Characterization of the Gag/fusion protein encoded by the defective Duplan retrovirus inducing murine acquired immunodeficiency syndrome. J. Virol. 64:5764-5772.
16. gag of the murine AIDS-defective virus is required to induce disease and notably for the expansion of its target cells. J. Virol. 68:5648-5655.
17. Huang, M., C. Simard, D. G. Kay, and P. Jolicoeur. 1991. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J. Virol. 65:6562-6571.
18. Jackson, P., and D. Baltimore. 1989. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J. 8:449-456.
19. Jolicoeur, P. 1991. Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogcncsis. FASEB J. 5:2398-2405. (Review.)
20. gag regions are both necessary for the pathogenicity of the murine AIDS virus. J. Virol. 68:5532-5537.
21. Luban, J., K. B. Alin, K. L. Bossolt, T. Humaran, and S. P. Goff. 1992. Genetic assay for multimerization of retroviral Gag polyproteins. J. Virol. 66:5157-5160.
22. Mayer, B. J., P. K. Jackson, and D. Baltimore. 1991. The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity. Proc. Natl. Acad. Sci. USA 88:627-631.
23. Morse, H. C., 3d, S. K. Chattopadhyay, M. Makino, T. N. Fredrickson, A. W. Hugin, and J. W. Hartley. 1992. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6:607-621.
24. Pendergast, A. M., A. J. Muller, M. H. Havlik, R. Clark, F. McCormick, and O. N. Witte. 1991. Evidence for regulation of the human abl tyrosine kinase by a cellular inhibitor. Proc. Natl. Acad. Sci. USA 88:5927-5931.
25. Pozsgay, J. M., M. W. Beilharz, B. D. Wines, A. D. Hess, and P. M. Pitha. 1993. The MA(p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus. J. Virol. 67:5989-5999.
26. Rassart, E., M. Shang, Y. Boie, and P. Jolicoeur. 1986. Studies on emerging radiation leukemia virus variants in C57BL/Ka mice. J. Virol. 58:96-106.
27. Ren, R., B. J. Mayer, P. Cicchetti, and D. Baltimore. 1993. Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157-1161.
28. Rivero-Lezcano, O. M., A. Marcilla, J. H. Sameshima, and K. C. Robbins. 1995. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol. Cell. Biol. 15:5725-5731.
29. Rosenberg, N., D. Baltimore, and C. D. Scher. 1975. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. USA 72:1932-1936.
30. Rosenberg, N., and O. N. Witte. 1988. The viral and cellular forms of the Abelson (abl) oncogene. Adv. Virus Res. 35:39-81.
31. + hematopoietic cells and their differentiation to granulocyte-macrophage progenitors. Blood 86:3387-3393.
32. Saksela, K., G. Cheng, and D. Baltimore. 1995. Proline-rich (PxxP) motifs in HIV-1 nef bind to SH3 domains of a subset of src kinases and are required for the enhanced growth of nef+ viruses but not for down-regulation of CD4. EMBO J. 14:484-491.
33. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
34. Sawyers, C. L., J. McLaughlin, A. Goga, M. Havlik, and O. Witte. 1994. The nuclear tyrosine kinase c-abl negatively regulates cell growth. Cell 77:121-131.
35. Schiestl, R. H., and R. D. Gietz. 1989. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16:339-346.
36. Schiff-Maker, L., M. C. Burns, J. B. Konopka, S. Clark, O. N. Witte, and N. Rosenberg. 1986. Monoclonal antibodies specific for v-abl-and c-abl-encoded molecules. J. Virol. 57:1182-1186.
37. Shi, Y., K. Alin, and S. P. Goff. 1995. Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the abl protein, suppresses v-abl transforming activity. Genes Dev. 9:2583-2597.
38. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
39. Van Etten, R. A., J. Debnath, H. Zhou, and J. M. Casasnovas. 1995. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro. Oncogene 10:1977-1988.
40. Van Etten, R. A., P. Jackson, and D. Baltimore. 1989. The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization. Cell 58:669-678.
41. Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian ras interacts directly with the serine/threonine kinase raf. Cell 74:205-214.
42. Wen, S. T., P. K. Jackson, and R. A. Van Etten. 1996. The cytostatic function of c-abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J. 15:1583-1595.
43. Wetzler, M., M. Talpaz, R. A. Van Etten, C. Hirsh-Ginsberg, M. Beran, and R. Kurzrock. 1993. Subcellular localization of bcr, abl, and bcr-abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J. Clin. Invest. 92:1925-1939.